Point72 Hong Kong’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-202
Closed -$18K 1960
2022
Q2
$18K Buy
202
+98
+94% +$8.73K ﹤0.01% 1139
2022
Q1
$16K Buy
104
+40
+63% +$6.15K ﹤0.01% 1069
2021
Q4
$19K Buy
+64
New +$19K ﹤0.01% 1004
2021
Q3
Sell
-5
Closed -$2K 1908
2021
Q2
$2K Sell
5
-15
-75% -$6K ﹤0.01% 1282
2021
Q1
$11K Buy
+20
New +$11K ﹤0.01% 1066